Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Protease Market, by Application
1.4.2 North America Protease Market, by Source
1.4.3 North America Protease Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Protease Market
Chapter 4. North America Protease Market by Application
4.1 North America Soap & Detergents Market by Country
4.2 North America Food & Beverages Market by Country
4.3 North America Animal Feed Market by Country
4.4 North America Pharmaceuticals Market by Country
4.5 North America Others Market by Country
Chapter 5. North America Protease Market by Source
5.1 North America Microbes Market by Country
5.2 North America Animals Market by Country
5.3 North America Plants Market by Country
Chapter 6. North America Protease Market by Country
6.1 US Protease Market
6.1.1 US Protease Market by Application
6.1.2 US Protease Market by Source
6.2 Canada Protease Market
6.2.1 Canada Protease Market by Application
6.2.2 Canada Protease Market by Source
6.3 Mexico Protease Market
6.3.1 Mexico Protease Market by Application
6.3.2 Mexico Protease Market by Source
6.4 Rest of North America Protease Market
6.4.1 Rest of North America Protease Market by Application
6.4.2 Rest of North America Protease Market by Source
Chapter 7. Company Profiles
7.1 Associated British Foods PLC (Wittington Investments Limited)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Koninklijke DSM N.V.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition, Mergers and Joint Ventures:
7.3 BASF SE
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 DuPont de Nemours, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Product Launches and Product Expansions:
7.5 Novozymes A/S
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Product Launches and Product Expansions:
7.6 Chr. Hansen Holding A/S
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segment & Regional Analysis
7.6.4 Research & Development Expense
7.7 Amano Enzyme, Inc.
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Product Launches and Product Expansions:
7.8 Advanced Enzyme Technologies Limited
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Research & Development Expenses
7.9 Biocatalysts Limited (Brain AG)
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Product Launches and Product Expansions:
7.10. Dyadic International, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Research & Development Expenses
Unique Offerings 